Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Category Archives: Diabetes
Rapid Update 3- October 2017: Type 2 Diabetes: Cardiovascular outcomes with pioglitazone versus sulfonylureas
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 3- August 2017: Type 2 diabetes: potential cardiovascular benefits with the SGLT2 inhibitor canagliflozin but with a greater risk of amputation
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Liraglutide: Cardiovascular outcome data in type 2 diabetes (Aug-16)
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Type 2 Diabetes: cohort study finds that compared with other antidiabetic drugs, sitagliptin and saxagliptin do not increase the risk of heart failure (May-16)
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Updated NICE guidance on Type-2 Diabetes – recommendations on drug treatments (Jan-16)
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Type 1 and 2 diabetes: new meta-analysis quantifies risks of smoking (Dec-15)
Authorised users need to be logged in to read this content.
Type 2 diabetes: potential cardiovascular and mortality benefits with empagliflozin treatment in high-risk individuals (Oct-15)
Authorised users need to be logged in to read this content.
Type 2 Diabetes: educational programme reduces inappropriate self-monitoring of blood glucose in type 2 diabetes (July 2015)
Authorised users need to be logged in to read this content.
Type 2 Diabetes: large RCT finds no effect of sitagliptin on the risk of cardiovascular events in people with type 2 diabetes and cardiovascular disease (July-15)
Authorised users need to be logged in to read this content.